Northeast Financial Consultants Inc acquired a new position in shares of Becton Dickinson and Co (NYSE:BDX) in the 1st quarter, Holdings Channel reports. The fund acquired 800 shares of the medical instruments supplier’s stock, valued at approximately $200,000.
Several other hedge funds and other institutional investors have also modified their holdings of BDX. Harvest Group Wealth Management LLC bought a new stake in Becton Dickinson and in the 1st quarter worth approximately $25,000. Pinnacle Financial Partners Inc. bought a new stake in Becton Dickinson and in the first quarter valued at approximately $29,000. RPG Investment Advisory LLC bought a new stake in Becton Dickinson and in the first quarter valued at approximately $32,000. Nalls Sherbakoff Group LLC bought a new stake in Becton Dickinson and in the fourth quarter valued at approximately $34,000. Finally, Aspire Private Capital LLC bought a new stake in Becton Dickinson and in the fourth quarter valued at approximately $39,000. 84.58% of the stock is owned by institutional investors.
Several analysts have weighed in on BDX shares. Morgan Stanley lowered their price objective on Becton Dickinson and from $255.00 to $250.00 and set an “equal weight” rating for the company in a research report on Friday, May 10th. Barclays boosted their price objective on Becton Dickinson and from $260.00 to $266.00 and gave the company an “equal weight” rating in a research report on Monday, April 15th. Raymond James lowered their price objective on Becton Dickinson and from $290.00 to $280.00 and set a “strong-buy” rating for the company in a research report on Tuesday, March 19th. Zacks Investment Research downgraded Becton Dickinson and from a “hold” rating to a “sell” rating in a research report on Monday, April 22nd. Finally, KeyCorp reiterated an “overweight” rating and issued a $262.00 price objective (down previously from $273.00) on shares of Becton Dickinson and in a research report on Friday, May 10th. Six investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $255.31.
In other news, Director Catherine M. Burzik purchased 285 shares of Becton Dickinson and stock in a transaction that occurred on Saturday, April 13th. The shares were bought at an average cost of $225.89 per share, with a total value of $64,378.65. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Betty D. Larson sold 1,700 shares of the company’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $224.97, for a total value of $382,449.00. Following the completion of the sale, the executive vice president now directly owns 11,493 shares in the company, valued at $2,585,580.21. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 21,154 shares of company stock worth $4,955,775. 0.12% of the stock is owned by insiders.
Shares of Becton Dickinson and stock opened at $234.16 on Friday. The company has a quick ratio of 0.59, a current ratio of 0.96 and a debt-to-equity ratio of 0.82. The company has a market cap of $63.94 billion, a P/E ratio of 21.27, a price-to-earnings-growth ratio of 1.75 and a beta of 1.12. Becton Dickinson and Co has a 52 week low of $208.62 and a 52 week high of $265.87.
Becton Dickinson and (NYSE:BDX) last announced its earnings results on Thursday, May 9th. The medical instruments supplier reported $2.59 EPS for the quarter, beating analysts’ consensus estimates of $2.57 by $0.02. The company had revenue of $4.20 billion during the quarter, compared to the consensus estimate of $4.25 billion. Becton Dickinson and had a return on equity of 14.58% and a net margin of 5.88%. The firm’s revenue for the quarter was down .6% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.65 earnings per share. On average, equities analysts predict that Becton Dickinson and Co will post 11.69 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 7th will be paid a $0.77 dividend. The ex-dividend date of this dividend is Thursday, June 6th. This represents a $3.08 annualized dividend and a yield of 1.32%. Becton Dickinson and’s payout ratio is 27.97%.
TRADEMARK VIOLATION NOTICE: “Northeast Financial Consultants Inc Takes Position in Becton Dickinson and Co (NYSE:BDX)” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2019/06/15/northeast-financial-consultants-inc-takes-position-in-becton-dickinson-and-co-nysebdx.html.
About Becton Dickinson and
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems.
Recommended Story: Average Daily Trade Volume – What You Need to Know
Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co (NYSE:BDX).
Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.